These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7541394)

  • 41. Argyrophil crystalloids in adenocarcinoma of the prostate.
    Luna-Moré S
    Prostate; 1993; 22(4):309-15. PubMed ID: 7684525
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship of neuroendocrine cells of prostate and serotonin to benign prostatic hyperplasia.
    Cockett AT; di Sant'Agnese PA; Gopinath P; Schoen SR; Abrahamsson PA
    Urology; 1993 Nov; 42(5):512-9. PubMed ID: 7694415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
    Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
    Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunohistochemical localization of keratin in human prostate.
    Kitajima K; Tökés ZA
    Prostate; 1986; 9(2):183-90. PubMed ID: 2428022
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phenotypic characterization of the infiltrating immune cells in normal prostate, benign nodular prostatic hyperplasia and prostatic adenocarcinoma.
    Hussein MR; Al-Assiri M; Musalam AO
    Exp Mol Pathol; 2009 Apr; 86(2):108-13. PubMed ID: 19111537
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disturbed homeostasis of zinc and other essential elements in the prostate gland dependent on the character of pathological lesions.
    Sapota A; Darago A; Taczalski J; Kilanowicz A
    Biometals; 2009 Dec; 22(6):1041-9. PubMed ID: 19629715
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acid and neutral cysteine proteinase inhibitor in normal uterine portio and in squamo-epithelial metaplasia, dysplasias and infiltrative carcinoma of the uterine portio.
    Rinne A; Järvinen M; Räsänen O; Hopsu-Havu VK
    Exp Pathol; 1984; 26(2):67-70. PubMed ID: 6548973
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heterogeneity of cathepsin B and stefin A expression in Gleason pattern 3+3 (score 6) prostate cancer needle biopsies.
    Sinha AA; Morgan JL; Wood N; Betre K; Reddy A; Wilson MJ; Ramanani DM
    Anticancer Res; 2007; 27(3B):1407-13. PubMed ID: 17595755
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: findings at radical prostatectomy.
    Chen YB; Fine SW; Epstein JI
    Am J Surg Pathol; 2011 Jul; 35(7):1054-61. PubMed ID: 21606823
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gray level entropy matrix is a superior predictor than multiplex ELISA in the detection of reactive stroma and metastatic potential of high-grade prostatic adenocarcinoma.
    Jia X; Sun Y; Wang B
    IUBMB Life; 2014 Dec; 66(12):847-53. PubMed ID: 25631296
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues.
    Maillard M; Cadot B; Ball RY; Sethia K; Edwards DR; Perbal B; Tatoud R
    Mol Pathol; 2001 Aug; 54(4):275-80. PubMed ID: 11477145
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of cysteine proteinases cathepsins B and K and of cysteine proteinase inhibitor cystatin C in giant cell tumor of tendon sheath.
    Hansen T; Petrow PK; Gaumann A; Keyszer GM; Otto M; Kirkpatrick CJ; Kriegsmann J
    Mod Pathol; 2001 Apr; 14(4):318-24. PubMed ID: 11301348
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma.
    Tamboli P; Amin MB; Schultz DS; Linden MD; Kubus J
    Mod Pathol; 1996 Oct; 9(10):1015-9. PubMed ID: 8902840
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DNA distribution in the prostate. Normal gland, benign and premalignant lesions, and subsequent adenocarcinomas.
    Berner A; Danielsen HE; Pettersen EO; Fosså SD; Reith A; Nesland JM
    Anal Quant Cytol Histol; 1993 Aug; 15(4):247-52. PubMed ID: 7691062
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Angiotensin AT(4) receptors in the normal human prostate and benign prostatic hyperplasia.
    Dinh DT; Frauman AG; Casley DJ; Johnston CI; Fabiani ME
    Mol Cell Endocrinol; 2001 Nov; 184(1-2):187-92. PubMed ID: 11694354
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mucin expression in atypical adenomatous hyperplasia of the prostate.
    Goldstein NS; Qian J; Bostwick DG
    Hum Pathol; 1995 Aug; 26(8):887-91. PubMed ID: 7543443
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tissue fibronectin levels of human prostatic cancer, as a tumor marker.
    Sönmez H; Süer S; Karaarslan I; Baloğlu H; Kökoğlu E
    Cancer Biochem Biophys; 1995 Nov; 15(2):107-10. PubMed ID: 8590435
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro high resolution 1H-spectroscopy of the human prostate: benign prostatic hyperplasia, normal peripheral zone and adenocarcinoma.
    Schiebler ML; Miyamoto KK; White M; Maygarden SJ; Mohler JL
    Magn Reson Med; 1993 Mar; 29(3):285-91. PubMed ID: 7680746
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinoma.
    Mazzucchelli L; Loetscher P; Kappeler A; Uguccioni M; Baggiolini M; Laissue JA; Mueller C
    Am J Pathol; 1996 Aug; 149(2):501-9. PubMed ID: 8701989
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.
    Bonkhoff H; Remberger K
    Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.